Status:
ENROLLING_BY_INVITATION
A Prospective Clinical Investigation to Evaluate the Safety and Performance of 877PTY Toric IOL for Visual Correction of Corneal Astigmatism
Lead Sponsor:
Medicontur Medical Engineering Ltd
Conditions:
Cataract
Corneal Astigmatism
Eligibility:
All Genders
18+ years
Brief Summary
Medicontur preloaded hydrophobic monofocal toric intraocular lenses (IOLs) are indicated to improve vision at far distance in adults with or without cataract and correction of pre-existing corneal ast...
Eligibility Criteria
Inclusion
- adult patients (18 years old and older);
- cataract and/or corneal astigmatism diagnosis;
- indication for cataract surgery or refractive lens exchange;
- recommended cylinder correction with toric IOL with cylinder power ≥1.0D;
- clear intraocular media other than cataract;
- signed informed consent form;
Exclusion
- irregular astigmatism;
- patients who are not targeted to emmetropia (predicted residual spherical equivalent and/or astigmatism is out of the range of ±0.5D and ±0.38D respectively);
- any retinopathy or maculopathy that affects the vision;
- iris neovascularization;
- congenital eye abnormality affecting visual performance;
- advanced glaucoma;
- pseudoexfoliation syndrome affecting IOL stability;
- amblyopia;
- uveitis;
- retinal detachment;
- prior ocular surgery in personal medical history;
- irregular corneal curvature or corneal diseases affecting visual performance;
- high myopia (axial length ≥ 26,5 mm);
- inadequate visualization of the fundus on preoperative examination;
- dilated pupil size not large enough to visualize toric IOL axis markings postoperatively based on the Investigator's decision;
- eye trauma in medical history;
- instability of keratometry or biometry measurements;
- prior corneal refractive surgery such as LASIK, PRK, or SMILE;
- patients deemed ineligible by the investigator because of any systemic disease or treatment;
- pregnancy or lactation;
- current use of systemic steroids or external ophthalmic drugs;
- concurrent participation in another drug or device investigation.
- Intraoperative exclusions: the presence of the following intraoperative exclusion criteria will lead to the exclusion of the subject:
- \- Any unexpected or serious intraoperative complication that makes IOL implantation impossible or results in implantation of another type of IOL that is outside the scope of this clinical trial.
Key Trial Info
Start Date :
April 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06578884
Start Date
April 16 2024
End Date
June 30 2025
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Győr-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház
Győr, Hungary, 9024